soul trial oral semaglutide cardiovascular outcomes 2024 results nejm Reduces CV Events in T2DM โ (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine ๐งช T2DM + ASCVD/CKD ๐ Oral semaglutide 14 mg vs placebo ๐ The SOUL trial (Semaglutide Cardiovascular
Description
Reconstituting the drug in this manner creates a liquid solution, purportedly the equivalent of the brand-name drug, which can then be injected under the skin
The semaglutide vs tirzepatide dosage chart helps compare the two compounds, and our guide on switching between the two covers the transition process
255 PocaiA
Equally effective as GLP-1 treatments
Our patience shall be rewarded
